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1. Abstract 
 
The G1 family of glutamic proteases is a novel family, first described in 2004. G1 proteases 
are characterized by high temperature optima (around 55°C) and acidic pH optima. Only G1 
proteases from fungi and a single G1 protease from bacteria have been characterized. The 
enzymatic activity of G1 proteases is dependent on a highly conserved catalytic dyad 
consisting of a glutamine and a glutamate residue. It has not been confirmed whether these 
residues are essential for the enzymatic activity of the bacterial G1 protease PepG1 from 
Alicyclobacillus sp. DSM 15716.  
AsaG1 and CmaG1, from the archaeal species Acidilobus saccharovorans and Caldivirga 
maquilingensis, respectively, have been annotated as putative G1 proteases. AsaG1 and 
CmaG1 have never been characterized to confirm their possible classification as G1 proteases. 
In this study, expression of AsaG1 and CmaG1 were attempted in Bacillus subtilis, 
Aspergillus oryzae and E. coli. Yet, expression could not be confirmed in any of the applied 
host organisms.  
PepG1 was point mutated by site-directed mutagenesis at Q117 and Q117+E199 that form the 
putative catalytic dyad, followed by expression in B. subtilis and characterization. Mutation of 
Q117 and Q117+E199 led to loss of enzymatic activity. It is therefore suggested that Q117 
and E199 are essential for the catalytic activity, and thereby form a catalytic dyad similar to 
that of formerly characterized fungal proteases. This gives strong evidence that PepG1 is 
correctly classified as G1 protease.  
2. Resume 
 
G1 familien af glutmiske proteaser er en ny enzymfamilie beskrevet første gang i 2004. G1 
proteaserne er karakteriseret ved høje temperatur optima (omkring 55°C) og lave pH optima. 
Indtil nu er kun fungale og en enkelt bakteriel G1 protease karakteriseret. Den enzymatiske 
aktivitet af G1 proteaser er afhængig af en konserveret katalytisk dyade, bestående af en 
glutamat og en glutamin enhed. Det er dog ikke bekræftet at disse aminosyrer er essentielle 
for den enzymatiske aktivitet i den bakterielle G1 protease, PepG1 fra Alicyclobacillus sp. 
DSM 15716.  
Archaea proteinerne AsaG1 og CmaG1 fra henholdsvis Acidilobus saccharovorans og 
Caldivirga maquilingensis, er blevet annoteret som formodede G1 proteaser. AsaG1 og 
CmaG1 er aldrig blevet karakteriseret, for at bekræfte om enzymerne kan klassificeres som 
G1 proteaser. I dette projekt blev ekspression af AsaG1 og CmaG1 forsøgt i Bacillus subtilis, 
Aspergillus oryzae og E. coli. Dog kunne ekspression ikke bekræftes i nogen af de anvendte 
værtsorganismer.  
PepG1 blev punktmuteret i Q117 samt Q117+E199, som udgør den formodet katalytiske 
dyade, efterfulgt af ekspression i B. subtilis og karakterisering af enzymet. Mutation af Q117 
samt mutation af Q117+E199 førte begge til tab af den enzymatiske aktivitet. Det er derfor 
forslået at Q117 og E199 er essentielle for den katalytiske aktivitet, og aminosyrerne udgør 
dermed en katalytisk dyade, tilsvarende dem i de tidligere karakterisere fungale G1 proteaser. 
Dette giver stærk evidens for at PepG1 er korrekt classificeret som G1 protease.    
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3.  Introduction 
 
The increased awareness of the potential gains in implementing the use of enzymes in 
industrial processes makes the enzyme industry a fast growing field. Heterologous expression, 
purification and characterization of enzymes are essential steps in elucidating enzyme 
substrate specificities and kinetics, and continuously lead to an increased understanding of 
enzymatic mechanisms in general [1, 2]. Production of enzymes is primarily done by 
heterologous expression of the enzyme-encoding gene in a microbial host like Bacillus 
subtilis or Aspergillus oryzae. These biochemical workhorses are used due to their ability to 
produce and secrete large amounts of enzymes. Moreover, these organisms are biological and 
biochemical well-characterized. Expression, in for example B. subtilis or A. oryae, can be 
valuable for scientific research possibilities of a specific enzyme, primarily because a large 
concentration is needed to investigate the enzyme [3, 4].  
Industrial enzymes meet different requirements, with regard to pH and temperature stability, 
to function under the conditions of industrial processes in which they are used. Some 
industrial processes can only be catalyzed by enzymes that are active under extreme 
temperature and pH. Thus, there is an increasing interest in acidophilic, alkaliphilic and 
thermophilic enzymes. Thermophilic enzymes are often found in organisms that exist in hot 
environments. Most characterized thermophilic enzymes are isolated from bacteria and fungi 
[5]. However, numerous archaea species are thermophilic, which makes these organisms 
potential sources of thermophilic enzymes. In addition, Archaea can be found in environments 
with extreme Ph [6]. Archaeal enzymes are potentially applicable for industrial usage, but 
are not yet of widespread use. Still, characterization of arcehaeal enzymes can contribute to an 
improved understanding of enzyme mechanisms and temperature/pH stability [7, 8]. 
 
The G1 protease family is a new family of acidic and thermosphilic enzymes, first described 
in 2004. Until now, only fungal and a single bacterial member (PepG1), have been 
characterized. Two thermophlic archeae species, Acidilobus saccharovorans and Caldivirga 
maquilingensis, encode AsaG1 and CmaG1, respectively. These are assigned to G1 family 
based on sequence homology [9, 10]. The enzymes have never been expressed or 
characterized, which is needed to confirm their possible classification as G1 proteases. This 
would provide a new understanding of this new enzyme family, and indicate that these 
enzymes exist in organisms other than bacteria and fungi.    
In this study the two archaeal species and the G1 family are summarizes, with regard to 
structure, mechanism and characteristics. This forms the basis for the hypothesis that AsaG1 
and CmaG1 share characteristics with the G1 proteases, which will be tested experimentally.   
The focus of this study was to elucidate the function of AsaG1 and CmaG1 by heterologous 
expression of the enzymes. Additionally the function of PepG1 was investigated by site-
directed mutagenesis and expression in B. subtilis.  
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4.  The archaea domain 
 
Archaea is the third domain of life, classified as a separate domain because it differs from 
both bacteria and eukaryotes. Archaea share some properties with both bacteria and 
eukaryotes with regard to for example morphology and metabolism. Still, archaea have some 
unique characteristics not seen in other organisms including a unique cell-membrane 
construction [11]. Genetically, archaea are related to both eukaryotes and bacteria, since 
archaea have some genes closely related to genes of both domains. This is possibly due to 
horizontal gene transfer events. Thus, it is estimated that 20 – 30 % of all archaeal genes 
originate from bacteria or eukaryotes [6].  
Most arcehaea are part of the two major phyla: Euryarchaeota and Crenarchaeota. 
Euryarchaeota is the most diverse phylum, which includes thermophilic, hyperthermophilic, 
mesophlic and psychrophilic organisms. Most Crenarchaeota species are thermophilic or 
hyperthermophilic [6]. 
Even though archaea have unique genetics, it is possible to express exstremophile archaea 
enzymes in mesophilic organisms. It has been reported that archaeal genes have been 
successfully expressed in mesophilic bacteria like E. Coli and B. subtilis, and mesophilic 
eukaryotes likes yeast [7].    
4.1 Acidilobus saccharovorans 
A. saccharovorans belongs to the Crenarchaeota phylum, and is found in a hot acidic spring 
of Kamchatka in Russia. It was isolated and characterized in 2009. The cells are cocci of 1–2 
µm in diameter. The organism is strictly anaerobic and heterotrophic. A. saccharovorans is 
hyperthermophilic, and is able to grow at a temperature range of 60-90 °C. The optimal 
growth temperature is 80-85°C. Additionally the organism is acidophilic. It grows at pH 2.5–
5.8 and has a growth optimum at pH 3.5–4.0 [12]. The complete genome sequence of A. 
saccharovorans was published in 2010. This showed that the species secretes several 
extracellular proteases. These were thought to be involved in proteolysis of extracellular 
peptides, which was imported into the cells and metabolized to be used as carbon and energy 
sources [13]. 
4.2 Caldivirga maquilingensis 
C. maquilingensis was found in the hot acidic spring “Mud Spring” in the Philippines. It 
belongs to the Crenarchaeota phylum and was isolated and characterized in 1999. The cells 
are rod-shaped with a size of 0.4-0.7 
.
 3-20 µm. Growth is possible under anaerobic and 
microaerobic conditions. The organism grows at 60-92°C and pH 2.3-6.4 with a growth 
optimum around 85°C and pH 3.7-4.2. Thus C. maquilingensis is thermophilic and 
acidophilic [14]. The C. maquilingensis genome was sequenced in 2007 [15].  
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5.  Glutamic Proteases – Famlily G1 
Proteases are enzymes that catalyze hydrolysis of peptide bonds within proteins [16]. Based 
on their active site mechanism, these enzymes are classified into seven groups, also called the 
catalytic types: The aspartic, cysteine, glutamic, metallo, asparagine, serine, and threonine 
proteases.   
The MEROPS database encompasses a hierarchical classification of proteases, in which the 
catalytic types are subdivided into families based on similarities in amino acid sequences. The 
G1 family, also called the eqolisins, is the first of two families of the glutamic protease group 
[10]. The G1 proteases belong to the endoproteases, which hydrolyze peptide bonds distant 
from the N- and C-termini of the substrate protein [10, 16]. G1 proteases are characterized by 
a pH optimum in the acidic range and a temperature optimum around 55°C [17–19]. The 
family is therefore regarded as acidophilic, thermophilic proteases [10]. 
The scytalidoglutamic protease (SGP) from the fungus Scytalidium lignicolum, was the first 
enzyme to be annotated to the new family in 2004  [20]. Since then, a total of 201 proteins 
have been reported to contain amino acid sequences similar to SGP, and have therefore been 
annotated as putative G1 proteases. These include both fungal, bacterial, and archeael proteins 
[10]. Only six of these proteins have been characterized including the aspergilloglutamic 
peptidase (AGP) from the fungus Aspergillus niger [9, 17–19, 21].  
Crystal 3D-structures of SGP and AGP (Figure 1) has shown that the proteases consist of a 
single polypeptide-chain of two seven-stranded anti-parallel β-sheets that compose a β-
sandwich. This structure is unseen in other proteins and therefore specific for the G1 family 
[20, 22]. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: The crystal structures of AGP and SGP. AGP: two seven-stranded β-sheets are shown in green and red 
respectively. The β-strands are numbered starting from the N-terminus to the C-terminus. SGP: two seven-
stranded β-sheets are shown in blue and red respectively. E136 and Q53 is part of the active site and described 
below. In both structures, the anti-parallel sheets overlap with each other, forming a characteristic β-sandwich. 
[20, 23]. 
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SGP and AGP have intermolecular disulfide bonds. These are conserved in some, but not all 
G1 proteases [20, 23]. It is proposed that the disulfide bridges, has an important role in 
stabilizing thermostabil enzymes at high temperatures. Thus the disulfide bridges might be 
involved in the high stability of SGP and AGP [24]. 
The molecular structures of SGP and AGP has indicated that two amino acid residues of 
glutamine and glutamate (Q107 and E190 in SGP, Q133 and E219 in AGP) are essential for 
their enzymatic activity [20, 22]. This has been confirmed by substituting the residues by site-
directed mutagenesis, which resulted in a loss of enzymatic activity of both AGP and SGP. 
Thus the two amino acid residues form a catalytic dyad, necessary for the activity [25–27]. It 
is reported that this dyad, the residues of the surrounding motifs, and four other motifs, are 
conserved in all G1 proteases. It is therefore believed that the Q-E dyad is important for the 
activity of all enzymes in the family, even though this has only been proven for SGP and AGP 
[10, 25, 26].   
It has been shown that G1 proteases are auto-processed into their mature structure under 
acidic conditions. This step is essential for activation the proteolytic mechanisms of the 
enzymes [25]. When activated, the G1 proteases can be assayed with collagen and casein as 
substrates. SGA and AGP are most active when casein is used, at pH 2 and 2.6 respectively 
[18, 19].  Moreover it has been shown that G1 proteases are not inhibited by pepstatin [17, 28, 
29]. This feature is unusual, since pepstatin is a common and potent inhibitor 
of numerous acidic proteases [30, 31].  
In 2004 a genomic analysis led to the conclusion that G1 proteases were found only in 
filamentous fungi [32]. However, in 2010, a putative bacterial G1 homolog (PepG1) from the 
bacterial strain Alicyclobacillus sp. DSM 15716 was characterized [9]. The amino acid 
sequence of PepG1 has 20.7% and 23.6% identity to SGP and AGP, respectively (calculated 
using Sequence alignments at UniProt [33]). Futhermore, it was reported that the aminoacid 
sequence of PepG1 included the conserved Q and E residues as well as the conserved motifs. 
PepG1 was expressed in B. subtillis and purified before characterization. PepG1 has pH and 
temperature optimums at 3-4 and 60°C, respectively. Furthermore, treatment with pepstatin 
has no effect on the enzymatic activity. The characteristics of pepG1 are very similar to the 
fungal G1 proteases, and PepG1 was therefore the first characterized bacterial enzyme in the 
G1 family [9].  
Based on the PepG1 sequence, several putative G1 homologs were identified [9]. Among 
these was CmaG1 from the Archaea species C. maquilingensis. AsaG1 from the Archaea 
species A. saccharovorans was earlier annotated as a putative G1 protease [9, 10]. CmaG1 
and AsaG1 have 22.48 and 19.37% identity to SGP, respectively, and 27.2% and 26.4% 
identity to PepG1,  respectively (calculated using Sequence alignments at UniProt [33]). 
Furthermore, the sequences include the conserved putative catalytic residues of Q and E, and 
the conserved motifs [9, 10]. These putative G1 proteases have not yet been characterized. 
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6.  Hypotheses 
 
Until now, only fungal and a single bacterial enzymes has been classified as G1 proteases 
[10]. AsaG1 and CmaG1 from Archaea species have been assigned to the G1 family. This has 
been done based on homology between CmaG1 and AsaG1 and the characterized G1 
proteases [10]. The assignation is further supported by an alignment analysis performed by 
Jensen et al., [9] which shows that AsaG1 and CmaG1 have 6 highly conserved mortifs and 
two catalytic residues of glutamine and glutamate (Q97 and E183 in AsaG1; Q92 and E175 in 
CmaG1). These are present in all characterized G1 proteases [9]. In addition, the C. 
maquilingensis and A. saccharovorans grows under conditions similar to the pH and 
temperature optima of the G1 proteases [12, 14]. The hypothesis is therefore that AsaG1 and 
CmaG1 have characteristics similar to those of the characterized G1 proteases. If this 
hypothesis is correct, CmaG1 and AsaG1 can probably be classified as the first archaeal G1 
proteases.  
 
CmaG1 and AsaG1 have never been heterologously expressed.  A. oryzae and B. subtilis are 
capable of high level expression and secretion of enzymes [3, 4]. Codon optimization has 
been reported to improve expression levels by decreasing the level of codons that are rarely 
used by the expression host organism [34]. It has been reported that codon optimization has 
led to an increased expression level for both A. oryzae and B. subtilis expression [35, 36]. In 
addition, codon optimized archaeal genes have earlier been used for heterologous expression 
with success [8]. It is therefore hypothesized that codon optimized AsaG1 and CmaG1 genes 
can be expressed in A. oryzae and B. subtilis.   
 
Molecular structures and site-directed mutagenesis has shown that two residues of Q and E 
are essential for the enzymatic activity of the characterized G1 proteases SGP and AGP [20, 
22, 25–27]. These residues are present in AsaG1, CmaG1, and PepG1, but it has never been 
confirmed if they are essential for enzyme activity [9, 10]. It is therefore further hypothesized 
that substitution of these residues by mutagenesis will lead to loss of enzymatic activity of 
AsaG1, CmaG1, and PepG1. The hypotheses were tested experimentally as described below. 
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7.  Materials and methods  
 
7.1 Chemicals 
All chemicals were obtained from Sigma Aldrich® and were of reagent grade quality or 
higher unless otherwise stated. 
 
7.2 Synthetic genes, amino acid sequences and primers  
Synthetic genes encoding AsaG1 and CmaG1 were codon optimized by GeneArt® (Life 
Technologies™) for A. oryzae and B. subtilis. The genes were received as a part of a plasmid 
containing a kanamycin resistance gene. All synthetic genes were obtained from GeneArt® 
(Life Technologies™). The DNA sequences of AsaG1, CmaG1 and PepG1 are shown in 
appendix.  
The signal peptides were identified from amino acid sequences (CmaG1 [ProtID 
ABW02092], PepG1 [ProtID ADG26771] and AsaG1 [ProtID YP_003816089]) using 
SignalP 4.0 [37]. The algorithm is designed for eukaryotic and bacterial protein sequences. 
For this purpose the shortest signal peptide cleavage prediction was chosen, to make sure that 
the enzyme did not lose N-terminal segments important for processing of the mature enzyme. 
Amino acid sequences of AsaG1, CmaG1 and PepG1 are shown in appendix, signal peptides 
are indicated.   
All primers were obtained from Sigma®. Primers for site-directed mutagenesis were designed 
in the stratagene primer design software (http://labtools.stratagene.com/QC). All primers 
sequences are shown in appendix.  
 
7.3 Substrates: 
All substrates were prepared by Novozyms A/S. The following growth media were used for 
A. oryzae growth: DAP-4C consisting of: 2% Dextrose, 1.1 % MgSO4·7H2O, 1% Maltose, 0.1 
% KH2PO4, 0.2 % citric acid, 0.1 % Dowfax 63N10 (antifoaming agent), 0.52% K3PO4
.
H2O, 
0.05%, Yeast Extract, 0.05 % Trace metal solution.  
YP 2% glucose consisting of: 1% Yeast extract (Difco), 2% Peptone Bacto (difco) 2% 
glycose. FG-4 consisting of: 3.0% degreased soymeal, 1.5% Maltodextrin 01 (Roquette), 
0.5% Pepton Bacto (Difco), 0.02% Dowfax 63N10 (antifoam). 
The following growth media were used for B. subtilis growth: PS-1 consisting of: 10% 
sucrose, 4% soymeal, 1% Na2HPO4 · 12 H2O, 0.01% Dowfax 63N10.  
CAL-18, consisting of: 4% yeast extract (Difco), 0.13 % MgSO4 · 7 H2O, 5% Maltodextrine, 
2% NaH2PO4 · H2O, 0.67% Na
2
MoO
4 
Trace metal solution and 0.01% Dowfax 
63N10(antifoaming agent).  
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A. oryzae selection agar plates contained Cove sucrose medium consisting of: 2% cove salts 
(2.6 % MgSO4.7H2O, 2.6% KCl, 7.6% KH2PO4 and 5% Cove trace metal solution). 34.2% 
Sucrose, 2% agar noble (Difco).  
The growth medium used for B. subtilis transformation, BCG medium consisted of: 90 mL 
H2O, 10 mL 10X MM (2% (NH4)2SO4, 6% KH2PO4 and 14% K2HPO4), 1 mL 10%  triNa-
citrat, 200 mL 1M MgSO4 
.
 7H2O, 100ml salt mix (0.4 mL 0.5 mol/L CaCL2 5.5%, 0.2 mL 
0.1 mol/L FeCl3, 6 H2O 2.7%, 0.2 mL 0.1 mol/L MnCl2,4 H2O 2.7%, 19.2 mL H2O, 0.5 ml 2 
mol/L HCL), 2mL 20% glucose (0.4%)   
 
7.4 Nucloetide sequence analysis  
DNA sequencing was done by Novozymes A/S, fungal screening. The sequencing, from both 
strands, was carried out using the Applied Biosystems 3730xl DNA Analyzer (Applied 
Biosystems) according to the instructions provided by the manufacture. 
  
7.5 Site-directed mutagenesis  
Point mutations were introduced into AsaG1, CmaG1 and PepG1 by site-directed 
mutagenesis. The applied method was inspired by the QuikChange® II Site-Directed 
Mutagenesis Kit (Stratagene). The method allows introduction of point mutations in double 
stranded plasmid DNA. The mutation is done by PCR with primers homologous to the 
template plasmid. The primers contain a mismatch responsible for the point mutation, since 
the PCR generates a new plasmid that is changed at the position of the mismatch. By 
treatment with Dpn I endonuclease, methylated and hemimethylated DNA is digested. 
Thereby the parental DNA is degraded and the newly synthesized mutated plasmid remains. 
The mutated plasmid will contain staggered nicks. To ligate the nicks, the plasmid is 
transformed into E. coli cells. The endogenous E. coli ligase ligates the nicks (Figure 2).    
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Figure 2 Primers with mismatches bind to each complementary strand of the plasmid. PCR-primer extension 
results in: a plasmid, mutated at the position of the primer mismatch, and hybrids between parental mutated 
DNA. Dpn I digests the parental plasmid, and the mutated plasmid remains. The mutated plasmid is transformed 
into E. coli. Staggered nicks are ligated by E. coli endogenous ligase. The gene of interest can be cloned into an 
expression host, or a new mutation can be introduced to the mutated plasmid.  
  
The three plasmids containing the B. subtilis codon optimized genes (AsaG1, CmaG1 and 
PepG1) were used as template for the site-directed mutagenesis. One amino acid substitution 
was introduced in each mutagenesis PCR. The second round mutagenesis PCR was carried 
out using the amplified mutagenesis product as template. The primers were designed to 
contain an alanine codon at the position of the glutamine or glutamate codon of interest. Thus, 
after two rounds of mutagenesis, a plasmid was generated, in which the glutamine and 
glutamate codons of interest were substituted with an alanine codon. The primers were: 
AsaG1-Q97fw, AsaG1-Q97rv, AsaG1-E183fw, AsaG1-E183rv, CmaG1-Q92fw, CmaG1-
Q92rv, CmaG1-E175fw, CmaG1-E175fw, CmaG1-E175rv, PepG1-Q82 fw, PepG1-Q82 rv, 
PepG1-E164 fw, PepG1-E164 rv. 
 
All reagents used in the PCR were obtained from the Phusion™ High-Fidelity DNA 
Polymerase kit (New England Biolabs). The reaction solution consisted of: 1x Phusion HF 
buffer, 0.2mM dNTP concentration, 0.5 μmol/L of each primer and 1 U Phusion High-
Fidelity DNA polymerase and 50 ng template DNA.  
The cycling conditions were: 
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 Denaturation: 98 °C, 30 s. 
 16 cycles of:  Denaturation: 98 °C 7 s; annealing 55 °C, 30 s; extension 72 °C, 5 min.  
 Final extension 72 °C, 10 min.  
 
The amplified plasmids were digested with Dpn I restriction enzyme for one hr. at 37°C. The 
mutated plasmids were transformed into E. coli Stellar™ competent Cells (Invitrogen). This 
was done by preincubation of the competent cells and mutated DNA, on ice for 30 min and 
heat shock at 42°C for 45 sec. followed by incubation in S.O.C. medium (Clontech) at 37°C 
foronehr. (shaking at 300 rpm). Selection of the clones was done on LB-plates supplemented 
with kanamycin (0.05 mg/mL). The clones were transferred from plates to overnight cultures 
containing LB bouillon supplemented with kanamycin (0.05 mg/mL). The cultures were 
incubated at 37°C for 12 hours (shaking at 200 rpm). Cells were harvested after 12 hours by 
centrifugation at 3000 G for 10 min. The plasmids were purified with QIAprep® Spin 
Miniprep Kit (QIAgen) according to the protocol provided by the manufacture. The 
mutagenesis sequences were confirmed by DNA sequencing on both strands. The following 
primers were used for sequencing: Asa/CmaG1 Seq fw, Asa/CmaG1 Seq fw, PepG1-F2 fw, 
PepG1-F2 rv. 
 
7.6 Construction of integration cassette for B. subtilis transformation  
An integration cassette was created, and integrated in the B. subtilis genome by homologous 
recombination. The cassette was designed to include regions flanking the gene of interest. 
These regions were homologous to the B. subtilis genome. Thereby, the cassette was 
integrated at a specific site on the genome. 
The cassette was created by joining three DNA fragments: fragment 1, 2 and 3 (Figure 3). 
Fragment 1 and 3 were the flanking regions homologous to the B. subtilis genome. Fragment 
2 was the inner region encoding the gene of interest (AsaG1, CmaG1 or PepG1, mutated and 
non-mutated). Fragment 1 and 3 were prepared by PCR of chromosomal DNA from the B. 
subtilis strain iMB1361. Fragment 1 included a triple promoter system, driving the 
heterologous expression. The promoter was from the Bacillus licheniformis alpha-amylase 
gene (amyL), the Bacillus amyloliquefaciens alpha-amylase gene (amyQ), and the Bacillus 
thuringiensis cryIIIA promoter, including a stabilizing sequence [38]. Furthermore, the 
fragment included a segment encoding a SAVINASE™-signal-peptide at the 3’-end 
(Novozymes A/S) which was included to obtain secretion of recombinant enzymes, and the 
chloramphenicol resistence gene (CAT), which was used as selection marker of B. subtilis 
clones. Fragment 3 included a SAVINASE™ terminator segment [38] and a 6xhistag at the 
5´end. Fragment 2 was prepared by PCR of the plasmids containing the B. subtilis codon 
optimized genes (AsaG1, CmaG1 and PepG1, mutated and non-mutated). Fragment 2 PCR-
primers were designed to include overlaps, which were homologous to fragment 1 and 3 
respectively. The overlap, homologous to fragment 1, included part of the SAVINASE™-
signal-peptide segment, which was replacing the native signal peptide of the gene of interest. 
The overlap homologous to fragment 3 included the 6xhis tag sequence. The three fragments 
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were assembled by splicing by overlap extension-PCR (SOE-PCR) (Figure 3). Addition of 
primers, homologous to the ends of the entire product, resulted in amplification of the 
integration cassette (Figure 3).  
 
Figure 3 Creation of integration cassette: Fragment 1 and 3 were amplified by PCR of the iMB1361 genome. 
The gene of interest was amplified by PCR creating fragment 2. The primers used for the amplification had 
overlaps homologous to fragment 1 and 3 respectively. All fragments were mixed in the SOE-PCR reaction. The 
overlaps were binding to fragment 1 and 2, and elongation resulted in one fragment. The fragment was amplified 
by addition of primers, homologous to each end of the fragment, which created the integration cassette. The 
primers used for colony PCR (7.7)  Bac-colony fw, Bac-colony rv, are indicated on the integration cassette. 
Fragment 2 of AsaG1, CmaG1 and PepG1 were amplified by PCR. The plasmids containing 
the codon optimized genes (both mutated and non-mutated) were used as templates. The 
following primers were used: PepG1-F2 fw, PepG1-F2 rv, AsaG1-F2 fw, AsaG1-F2 rv, 
CmaG1-F2 fw, CmaG1-F2rv. 
All reagents used in the reactions were obtained from the Phusion™ High-Fidelity DNA 
Polymerase kit (New England Biolabs). The reaction solution consisted of: 1x Phusion HF 
buffer, 0.2mM dNTP concentration, 0.5 μM of each primer and 1 U Phusion High-Fidelity 
DNA polymerase with 100 ng template DNA. The cycling conditions were:  
 
 Denaturation: 98 °C, 30 s. 
 30 cycles of:  Denaturation: 94 °C 10 s; annealing 60 °C, 30 s; extension 72 °C, 1 min.  
 Final extension: 72 °C, 5 min.  
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Fragment 1 and 3 were amplified by PCR. B. subtilis strain iMB1361 genomic DNA was used 
as template. The reverse primer used to amplify fragment 3 included an overlap containing 
the 6Xhis-tag DNA sequence. The following primers were used: F1fw, F1rv, F3fw, F3rw. 
The reaction solution consisted of: 1x Phusion HF buffer, 0.4 mM dNTP concentration, 1 μM 
of each primer and 1 U Phusion High-Fidelity DNA polymerase with 100 ng template DNA.  
The cycling conditions were:  
 
 Denaturation: 98 °C, 2 min. 
 10 cycles of:  Denaturation: 98 °C, 15 s; annealing 60 °C, 45 s; extension 72 °C, 4 min.  
 20 cycles of:  Denaturation: 98 °C, 15 s; annealing 60 °C, 45 s; extension 72 °C, 4 min (+ 20 s 
pr cycle) 
 Final extension 72 °C, 10 min.  
 
The PCR-products were loaded on a 1% agarose gel with 1X SYBR® Safe DNA Gel Stain 
(Invitrogen). The gel slices containing the bands of the correct sizes, were purified by GFX 
PCR DNA and Gel Band Purification Kit (GE healthcare) according to the protocol provided 
by the manufacture. 
 
The fragments were assembled by SOE-PCR (Figure 3). The following primers were used: 
F1fw, F3fw.  
The reaction solution consisted of: 1x Phusion HF buffer, 0.4 mM dNTP concentration, 0.25 
μM of each primer, 1 U Phusion High-Fidelity DNA polymerase, 50 ng fragment 1 and 38,4 
ng fragment 3. Different amounts of the fragment 2 were used, dependent on fragment length: 
7 ng AsaG1, 8,3 ng CmaG1 and 8,5 ng PepG1 (both mutated and non-mutated).   
The cycling conditions were: 
 
 Denaturation: 98°C, 2 min 
 10 cycles of: 
Denaturation: 98°C, 2 min; annealing: 50°, 45 s; extension: 72°C, 5 min 
 10 cycles of: 
Denaturation: 98°C, 2 min; annealing: 60°, 45 s; extension: 72°C, 8 min 
 15 cycles of: 
Denaturation: 98°C, 2 min; annealing: 60°, 45 s; extension: 72°C, 8 min + 20 s pr. Cycle. 
 Final extension: 72°C, 5 min 
 
The primers were added after the first 10 cycles.  
The SOE-product was loaded on a 1% agarose gel with 1X SYBR® Safe DNA Gel Stain 
(Invitrogen) to confirm that the PCR was successful. 
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7.7  B. subtilis transformation  
Expression of AsaG1, CmaG1 and PepG1 genes was done in the B. subtilis expression strains 
A and B. Strain B is a protease deficient strain.   
The integration cassettes were transformed into strain A or B. When B. subtilis are starved 
they enter a stage, in which they are able to bind DNA and transport it across the cell 
membrane, which make these organisms natural competent. Thereby DNA can be 
transformed into B. subtilis without chemical or physical treatment of the cells [39]. 
The B. subtilis cells (strain A or B (protease deficient)) were made competent by Novozymes 
A/S, Bacterial Screening, as described earlier [39]. The transformation was done by 
incubation of: the 2 µL SOE-product, 50 µL competent cells and 50 µL BCG-mix containing: 
5 μL 2 mmol/L EGTA, 5 μL 0.4 mol/L MgCl2 and 40 μL BCG medie. This was incubated at 
37°C for 20 min. Selection of clones was done on LB-plates supplemented with 
chloramphenicol (6 mg/L). 
 
The gene insertion was confirmed by colony PCR and sequencing. Each colony was 
suspended in 10 µL H2O. DNA was released by incubation for 5 min at 95°C.  1 µL Released 
DNA was resuspended in 11 µL of a reaction solution containing: 1X PCR Reddymix PCR 
Master Mix (Thermo scientific) and 0.5 µmol/L of each primer. The following primers were 
used for the colony PCR: Bac-colony fw, Bac-colony rv.   
The cycling conditions were:  
 Denaturation: 94 °C, 3 min. 
 30 cycles of:  Denaturation: 94 °C 30 s; annealing 60 °C, 1 min; extension 72 °C, 1.5 min.  
 Final extension 72 °C, 10 min. 
The PCR products were loaded on a 1% agarose gel with 1X SYBR® Safe DNA Gel Stain 
(Invitrogen). Three constructs were chosen for sequencing based on the intensity of the bands 
on the agarose gel. The PCR product was purified from the PCR mixture by GFX PCR DNA 
and Gel Band Purification Kit (GE healthcare) as described in the protocol provided by the 
manufacture. The PCR products were DNA sequenced on both strands to confirm the 
sequence of the insert (according to 7.4).   
 
7.8 Fermentation of B. subtilis clones 
A clone with confirmed DNA-sequence was chosen for fermentation. The clones were grown 
in PS-1 (Strain A clones) or Cal-18 (Strain B clones) supplemented with chloramphenicol (6 
mg/L). The fermentation was done in shaking flasks at 30°C and/or 37°C, shaking at 225 rpm.    
 
7.9 Construction of expression vector for A. oryzae  
A. oryzae strain MT3568 was used as expression host for expression of AsaG1 and CmaG1. 
The strain is capable of high level secretion of enzymes. MT3568 is a derivative of A. oryzae 
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strain JaL355, described in [40], in which the amdS gene encoding acetamidase has been 
disrupted.   
The A. oryzae expression was done by cloning of AsaG1 and CmaG1 into expression vector 
pDau109 (Figure 5), which is described in [41]. The vector is a shuttle vector, capable of 
replication in E. coli, and random integration on the A. oryzae genome. pDau109 encodes an 
ampicillin resistance gene of β-lactamase for selection of E. coli clones. In addition an E. coli 
origin is part of the plasmid. The A. oryzae expression is driven by the NA2TPI promoter 
(Figure 4). This promoter is a hybrid between natural promoters of Aspergillus niger and A. 
oryzae. The gene of interest is inserted between NA2TPI and Tamg, which is the terminator 
of amyloglycosidase from Aspergillus niger. After the NA2TPI promoter is a signal peptide 
from Candida Antarctica, which was replacing the native signal peptide of the insert (CmaG1 
and AsaG1), to obtain secretion of recombinant enzymes. pDau109 has an amdS gene, 
encoding the acetamidase enzyme (Figure 5). This can be used as selectable marker in the 
amdS free MT3568 strain when grown on medium with acetamide as the only source of 
nitrogen [41]. 
 
Figure 4  Schematic illustration of the pDAU109 with: NA2TPI promoter, MluI restriction site, Tamg 
Aspergillus niger amyloglycosidase terminator, amdS acetamidase gene, E. coli origin, AmpR (β-lactamase) and 
Pna2: Aspergillus nidulans triose phosphate isomerase non translated leader sequence (to enhance the expression 
level). The illustration was created in vector NTI advanced™ version 10.3.0. 
The A. oryzae codon optimized genes were amplified by PCR and were cloned into the 
pDau109 vector. These were transformed into MT3568. The following chart illustrates an 
overview of the A. oryzae cloning. Below, the method is described step by step.  
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pDau109 was digested by MluI (Fermentas). The reaction contained 1000 ng plasmid DNA 
and 10 U MluI. The digested vector was loaded on an agarose gel and purified as described in 
7.5. The gene inserts of AsaG1 and CmaG1 were amplified by PCR. The plasmids containing 
the codon optimized genes were used as template. The primers were designed to contain 
overlaps homologous to the pDau109. The 3’end of the overlap included a 3Xhis-tag 
segment. At the 5’-end of the linearized vector was additionally a 3Xhis-tag segment; together 
these formed a 6Xhis-tag when assembled. AsaG1 and CmaG1 were amplified without their 
signal peptide segments (indicated in appendix). The native peptides were replaced with a 
C. Antarctica signal peptide.  The following primers were used: AsaG1 oryzae fw, AsaG1 
oryzae rv, CmaG1 oryzae fw, CmaG1 oryzae rv. 
All reagents used in the reaction were obtained from the Phusion™ High-Fidelity DNA 
Polymerase kit (New England Biolabs). The reaction solution consisted of: 1x Phusion HF 
buffer, 0.2mM dNTP concentration, 0.5 μM of each primer and 1 U Phusion High-Fidelity 
DNA polymerase with 100 ng template DNA.  
The cycling conditions were:  
 
 Denaturation: 94 °C, 30 s. 
 30 cycles of:  Denaturation: 94 °C 10 s; annealing 60 °C, 30 s; extension 72 °C, 1 min.  
 Final extension 72 °C, 5 min.  
 
The gene of interest and the vector were assembled by binding of the overlapping sequences 
and the linearized vector. This was done by the In-Fusion® HD EcoDry™Cloning Kit 
(Clontech) as described in the protocol provided by the manufacture.  
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To amplify the pDau109, the vector was transformed into E. coli Stellar™ Competent Cells as 
described in 7.5. Selection of the clones was done on LB-plates supplemented with ampicillin 
(0.1 mg/mL).  
 
The gene insert was confirmed by colony PCR followed by DNA sequencing. Two colonies 
were chosen. Each colony was suspended in 11 µL PCR reaction mix consisting of: 1X PCR 
Reddymix PCR Master Mix (Thermo scientific) and 0.5 µmol/L of each primer. The 
following primers were used for the colony PCR: Pna-fw, and Tamg-rv. 
The cycling conditions were: 
 
 Denaturation: 94 °C, 2 min. 
 30 cycles of:  Denaturation: 94 °C 15 s; annealing 60 °C, 30 s; extension 72 °C, 2 min.  
 Final extension 72 °C, 10 min.  
 
The PCR product was loaded an agarose gel and purified as described in 7.5. The PCR 
products were DNA sequenced on both strands to confirm the sequence (according to 7.4).  
The clones was transferred from plates to overnight cultures containing LB bouillon 
supplemented with ampicillin (0.1 mg/mL). The cultures were incubated at 37°C. Cells were 
harvested after 12 hours by centrifugation at 3000 G for 10 min. The plasmids were purified 
as described in 7.5. 
 
7.10 Transformation into MT3568  
To make fungi like A. Oryzea capable for transformation, the cell wall must be digested with 
enzymes. After the treatment the cells are protoblasts, without cell walls, which are able to 
take up foreign DNA [42]. MT3568 Protoplasts were prepared by Novozymes A/S, fungal 
screening as earlier described [43]. The expression vectors with inserts were transformed 
into MT3568 Protoplast according to [4] and [44]. This was done by mixing 10 µL DNA with 
100 µL of the protoblasts, which was resuspended in 270 µL Polyethylene glycol (PEG) 
followed by incubation 30 min at 37°C. The selection was done on cove sucrose plates 
supplemented with acetamid (0.01 mol/L).  
 
7.11 Fermentation of A. Oryzea clones  
The clones were grown in shaking flask containing DAP-4C-1 supplemented with 2.1% 
(NH4)2HPO and 1% lactic acid, YPG and FG-4 at 30°C or 37°C shaking at 150 rpm. 
    
7.12 Construction of expression vector for E. coli  
The E. coli expression of AsaG1 and CmaG1 was done in E. coli strain XJb Autolysis™. This 
strain is a derivative of E. coli BL21 with λ lysozyme inserted on the bacterial chromosome. 
The lysozyme can be induced by arabinose. During growth, cells are not digested by the λ 
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lysozyme, because the peptidog lycan layer is protected by the cytoplasmic membrane. Still 
the membrane can be disrupted by physico-chemical stress. Therefore the cells are lysed by a 
freezethaw cycle.  
pET32a(+) (Figure 5) was used as expression vector for E. coli expression of AsaG1 and 
CmaG1. The vector contains the ampR gene, which was used for selection. The genes of 
interest were inserted between the XhoI and NdeI restriction sites. Thus, the expression was 
driven by the T7 promotor. Expression must be induced by IPTG to prevent repression of the 
lac operator. The expressed protein will include a 6X his-tag at the C-terminal.   
 
Figure 5 Schematic illustration of the pET-32a(+) with:, ampR ampicilin resistens gene, plasmid origin, T7 
promotor, lac operator, two NdeI restriction sites, XhoI restriction site and a 6Xhis-tag. The illustration was 
created in vector NTI version advanced™ version 10.3.0. 
 
The B. subtilis codon optimized genes were amplified by PCR and assembled with the 
linearized vector creating pET32a(+)/AsaG1 and pET32a(+)/CmaG1. The genes were 
expressed intracellular without signal peptide. The vectors were transformed into the E. coli 
expression strain XJb Autolysis™ followed by fermentation. The following chart illustrates 
the method of the E. coli cloning. Below the methods is described step by step.  
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The pET32a(+) vector was linerized by restriction enzyme digestion by XhoI and NdeI 
(Fermentas). The reaction contained of: 1000 ng plasmid DNA, 1X NEBuffer 4, 10 U NdeI, 
10 U XhoI and 100 µg/mL BSA (New England Biolabs). The reaction was incubated for 60 
min at 37°C. The linerized pET32a(+) was loaded on an agarose gel and purified as described 
In 7.5.  
The gene inserts were prepared by PCR. The primers used for the PCR were designed to 
contain 15 bp overlaps. The overlaps were homologous to the ends of the linearized vector. 
Thus the amplified AsaG1 and CmaG1 inserts contained 15 bp at the 3’- and 5’-end, 
homologous to the linerized vector. The following primers were used for the PCR: Asa-coli 
fw, Asa-coli Rv, Cma-coli Fw, CmaG1-coli rv. 
The plasmids containing the B. subtillis codon optimized AsaG1 and CmaG1 genes, were 
used as template for the PCR (both mutated and non-mutated). All reagents used in the PCR 
were obtained from the Phusion™ High-Fidelity DNA Polymerase kit (New England 
Biolabs). The reaction solution consisted of: 1x Phusion HF buffer, 0.2mM dNTP 
concentration, 0.5 μM of each primer and 1 U Phusion High-Fidelity DNA polymerase with 
50 ng template DNA. The cycling conditions were:  
 
 Denaturation: 98 °C, 30 s. 
 30 cycles of:  Denaturation: 98 °C 30 s; annealing 60 °C, 1 min; extension 72 °C, 1 min.  
 Final extension 72 °C, 5 min.  
 
The PCR-products were loaded on an agarose gel purified as described in 7.5. 
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The overlapping sequences of the PCR product were assembled with the linearized vector. 
This was done by the In-Fusion® HD EcoDry™Cloning Kit (Clontech), as described in the 
protocol provided by the manufacture.  
 
The plasmids were amplified by transformation into E. coli Stellar™ competent cells as 
described in 7.5. Selection of the clones was done on LB-plates supplemented with ampicillin 
(0.1 mg/mL). The gene insert sequence was confirmed by colony PCR followed by DNA 
sequencing as described in 5.9. The primers used for gene inserts preparation PCR was used 
for sequencing.  
The clones were transferred from plates to overnight cultures containing LB bouillon 
supplemented with kanamycin (0.05 mg/mL). Plasmids were purified as described in 7.5. 
 
7.13 Cloning and expression in XJb Autolysis™  
The amplified expression vectors were transformed into E. coli XJb Autolysis™. The 
transformation was done by preincubation of XJb cells and the vector on ice for 30 min and 
heat shock at 42°C for 45 sec. followed by incubation in S.O.C. medium (Clontech) at 37°C 
for one hr. (shaking at 300 rpm). Selection of the clones was done on LB-plates supplemented 
with ampicillin (0.1 mg/mL).  
The clones were transferred to overnight cultures containing LB supplemented with 
ampicillin (0.1 mg/mL). These were incubated at 37C° for 12 hours. Overnight cultures were 
transferred to shaking flask containing LB supplemented with ampicillin (0.1 mg/mL), L-
arabinose (3 mmol/L) and MgCl (1 mmol/L), to reach OD600 at 0.02. The flasks were 
incubated in 30°C and 37°C shaking at 200 rpm. The expression was induced by IPTG when 
OD600 0.7 was reached. Meanwhile, OD600 was measured five times to confirm exponential 
growth.  
The cells were harvested by centrifugation at 5000 rpm for 10 min. The pellets were 
resuspended 100 mmol/L sodium phosphate buffer (pH7). The solutions were frozen and 
thawed. DNase (fermentas) was added to the lysed cells to make the solution less viscous. 
The supernatant was isolated by centrifugation at 5000 rpm for 10 min. 
 
7.14 SDS-page and spot-test  
To confirm expression in B. subtilis, A. oryzae and E. coli, cultures supernatant were analyzed 
by SDS-page after fermentation. B. subtilis clones were harvested by centrifugation of the 
culture broth at 3000 G for 10 min, the supernatant was used for analyses.  A. oryzae clones 
were harvested by centrifugation of the culture broth at 5000 rpm for 10 min, the supernatant 
was used for analyses. The supernatant from the E. coli lysate was used for analyses. To 
precipitate and inactivate the proteases, the supernatant was treated with 50% trichloracetic 
acid (TCA) to a final TCA concentration of 10%, followed by centrifugation at 10.000 G for 
three min. The pellets were resuspended in 2x modified SDS-sample buffer (Invitrogen) and 
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denatured at 95°C for three min. The SDS-buffer was modified to neutralize the pH after TCA 
treatment. This was prepared by mixing TRIS base (3 mol/L) and SDS buffer in a 1:10 ratio. 
Samples were loaded on novex® 4-20% tris-glycerine SDS-gels (Life technologies) and 
stained with InstantBlue™ (Expedeon).     
The protease activity level was estimated by spot test of the culture supernatant. Three 
substrates were used for the spot tests: AZCL-casein, AZCL-collagen and skim-milk. The 
AZCL activity was determined from 1% agarose plates, containing 100 mmol/L sodium 
phosphate buffer or 50 mmol/L citric acid buffer (only for pH 4 plates) at different pH. The 
plates contained 0.04% of one of the mentioned substrates. AZCL forms a blue halo around 
the spot if the substrate proteins are degraded. The size of the blue halo around the spot 
represents an estimate of the protease activity level. The skim milk plates were 1% agarose 
plates at different pH with 10% skim milk. On skim-milk plates a clearing zone appears if 
protease activity is present. The size of the clearing zone represents an estimate of the 
protease activity level. 20 µL of the supernatant spotted on AZCL and/or skim milk plates. 
The plates were incubated at different temperatures for 12 hours.  
Some samples were treated with hydrochloric acid and different temperatures (50-80°C) 
before SDS and spot tests (indicated in results) for 20 min. The treatment was followed by 
centrifugation at 16.000 G for three min. This was done to isolate the G1 proteases, which 
were believed to be resistant to high temperatures and low pH.  
        
7.15 Protein purification  
Protein purification was carried out using the His SpinTrap kit (GE Healthcare) on the culture 
supernatant according to the protocol provided by the manufacture. The culture supernatant 
was washed with binding buffer with an imidazole concentration of 20 mmol/L and eluted 
with elution buffer with an imidazole concentration of 500 mmol/L as recommended by the 
manufacture.  
 
7.16 Protease assays  
Protease assays were carried out using culture supernatant, prepared as described in 5.15. 
Supernatants from A. oryzae AsaG1 and CmaG1 clones and the B. subtilis PepG1 clone were 
used. For assays of AsaG1 and CmaG1, both 0.04% AZCL collagen and casein were used as 
substrates. The substrates were resuspended in 50 mmol/L citric acid buffer at pH 2 or 3. 100 
µL culture supernatant was resuspended in 1000 µL assay mix. This was incubated at 60°C 
for 30 min shaking at 1000 rpm in a thermomixer. To stop the reaction the solution was 
placed on ice. For the assay of PepG1, 0.04% AZCL collagen was used as substrate. The 
substrate was resuspended in 50 mmol/L citric acid buffer at pH 2. 50 µL culture supernatant 
was resuspended in 250 µL assay mix. This was incubated at 60°C for 45 min shaking at 1000 
rpm in a thermomixer. 
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After the reaction, the samples were centrifuged at 10000 G for three min, and 200 µL 
supernatant was transferred to microtiter plates. OD590 was measured on spectraMax® 
plus384 absorbance mictroplate reader (Molecular devices). An increase in absorbance 
indicated increased Activity. A blind including the assay solution and H2O (instead of culture 
supernatant) was used as reference. The relative activity was calculated by: OD590-sample – 
OD590-blind.  
 
7.17 DNA sequence and alignment analyses 
DNA sequences were analyzed and compared to native sequences (shown in appendix) using 
SeqMan software (DNASTAR).   
Amino acid identity was calculated using Sequence alignments at UniProt [33].  
The amino acid alignment analysis was carried out by aligning of sequences using ClustalX 
version 2.0.11 [45]. The graphical illustrations of the alignment was carried out using Jalview 
version 2.8 [46].  
 
7.18 Statistical analysis 
Analysis of datasets was performed by twotailed Student’s t-test. All tests were considered 
statistically significant at p ≤ 0.05. 
 
7.19 N-terminal sequencing 
Automated Edman degradation of purified pepG1 was carried out by Novozymes A/S using 
Perkin-Elmer ABI 494HT sequencer with online microbore phenylthiohydantoin-amino acid 
detection. 
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8. Results 
 
8.1 Alignment 
The 6 characterized G1 proteases, AsaG1, and CmaG1 were analyzed in an amino acid 
alignment (Figure 6).   
 
Figure 6 Multiple sequence alignment analysis of characterized G1 proteases and the archaeal putative G1 
proteases. The characterized poteases used for the alignment were scytalidoglutamic peptidase (SGP, [Uniprot 
P15369]) from Scytalidium lignicolum, aspergilloglutamic peptidase (AGP, [Uniprot P24665] from Aspergillus 
niger, acid peptidases B and C (EapB [(EapB [Uniprot Q00550] and EapC [Uniprot Q00551]) from 
Cryphonectria parisitica,  Penicillium marneffei acid proteinase (PMAP-1, [GenBank: EEA28697])  from 
Penicillium marneffei and PepG1 [ProtID ADG26771] from Alicyclobacillus sp. DSM 15716. The archaeal 
putative G1 proteases used for the alignment were AsaG1 [ProtID YP_003816089] from Acidilobus 
saccharovorans and CmaG1 [ProtID ABW02092] from Caldivirga maquilingensis. The 7 conserved mortifs, 
identified by Fujinaga et al. [20] are indicated with boxes. The alignment is colored based on percentage identity 
of the residues.  indicates > 80%, > 60%,  > 40% and white < 40% identity.  indicates the catalytic 
residues, and  indicates cysteines involved in disulfide bonds. The alignment was generated using ClustalX 
version 2.0.11 [45]. The illustration was made in Jalview version 2.8 [46].  
 
 
The alignment shows an overall low homology between the archaeal and fungal G1 proteases, 
except for the conserved boxes identified by Fujinaga et al. [20] and a few other separate 
residues. AsaG1 and CmaG1 have an evident similarity to the characterized G1 proteases in 
these boxes. Additionally the boxes show the highest degree of identity between the aligned 
proteases. The catalytic G and Q residues, identified earlier [20, 22], are present in all aligned 
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proteases. The conserved disulfide bonds are not present in the bacterial and the putative 
archaeal G1 proteases.  
 
8.2 Mutation and b. subtilis expression of PepG1  
The synthetic codon optimized PepG1 gene encoding the bacterial G1 protease was mutated 
by site-directed mutagenesis to introduce an alanine replacement of Q117 and E199 
(described in 7.5). The mutated plasmids were transformed into E. coli (stellar®).  Plasmids 
were purified and the genes of interest sequences were confirmed by DNA sequencing from 
both strands (according to 7.4). Expression of the mutated and non-mutated genes was done in 
B. subtilis Strain A. This was done by generation of an integration cassette encompassing the 
gene of interest (mutated and non-mutated) and two regions for homologous recombination 
(described in 7.6). The integration cassette was transformed into B. subtilis strain A and 
incorporated in the genome by homologous recombination (described in 7.7). PCR on 
colonies was used for verifying integration of the cassette, the gene of interest was amplified, 
and correct sequence of the mutated and non-mutated inserts were verified by DNA 
sequencing of the PCR products, the entire sequences were sequenced from both strands 
(described in 7.4 and 7.7). 
 
8.2.1 Generation of integration cassette for B. subtilis expression of mutated and non-
mutated PepG1  
The verified Q-mutated, the Q+E-mutated, and the non-mutated PepG1 genes were amplified 
to create fragment 2, which was used for creation of the integration cassette, which was 
transformed into B. subtilis (desicribed in 7.7). The following fragments were amplified: 
 
 
Fragment 1:      5184 bp 
Fragment 2 PepG1:    864 bp 
Fragment 2 PepG1 Q117-mutation:   864 bp 
Fragment 2 PepG1 Q117 and E199 –mutations:  864  bp 
Fragment 3-his:    2904 bP
fragment 2 was assembled with fragment 1 and 3, to create three integration cassettes (Figure 
7).   
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8.2.2 Transformation of integration cassettes of mutated and non-mutated PepG1 into B. 
subtilis    
The integration cassettes were transformed into B. subtilis expression strain A (described in 
7.7). Eight clones were picked; the inserts were amplified by colony PCR and loaded on an 
agarose gel (described in 7.7). The correct inserts of all clones were observed on the agarose 
gel. Three insert were purified and the entire genes of interest were sequences from both 
stands, which confirmed the insert sequence in one of these (described in 7.4).  
 
8.2.3 Protease activity tests of mutated and non-mutated PepG1   
The verified clones were fermented in PS-1 in at 37°C as described 7.8. After three days of 
fermentation, the supernatant was spotted on casein at pH 6 and incubated at 50°C (described 
in 7.14). In The non-mutated PepG1 activity was observed, contrary to the mutated PepG1 
clones and in the empty Strain A host (Figure 8 A). After four days of fermentation a protease 
assay was carried out on the culture supernatant, as described in 7.16. Collagen was used as 
substrate at pH 2 (Figure 8 B). The assay showed that the activity of the non-mutated PepG1 
was significantly higher than the background activity (empty strain A host). Furthermore the 
activity of the clones, with the two mutated PepG1 construct, showed no significant 
difference from the background activity. The diagram shows a sizeable higher activity of the 
non-mutated PepG1 compared to the mutated constructs (Figure 8 B).  
 
 
 
 
 
M 1 2 3
Figure 7: Agarose gel illustrating the 
SOE-PCR products (integration cassette) 
of PepG1. Fragment 1, 2, and 3 were 
assembled to create the integration 
cassette. 1: The non-mutated PepG1. 2: 
PepG1 with Q117 mutation. 3: PepG1 
with Q117 and E199 mutation. The 
expected size of the products was: 8952 
bp. The topmost bands corresponded to 
the theoretical size of the SOE-PCR 
products (other bands might be 
unassembled fragments). M: 
Hyperladder™ I marker 
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8.2.4 Heat treatment and SDS-page of mutated and non-mutated PepG1  
After three days of fermentation in PS-1 at 37°C (described in 7.8) SDS-page analysis was 
carried out on the culture supernatants (described in 7.14). The gel included a lot of 
background proteins and was therefore not shown. 
After four days of fermentation, the culture supernatant of the PepG1 clones (both mutated 
and non-mutated) were heat treated at 70°C as described in 7.14. Hydrochloric acid was 
added to 
a final concentration of 0.13 mol/L (until pH 5 was reached) to remove non-heat and non-acid 
stable enzymes (described in 7.14). A mini protease assay of single determinations on 
collagen pH 2, was performed (described in 7.16) to confirm that the activity was not lost in 
PepG1 after heat treatment. The activity was present in PepG1 and still not present in the 
mutations and the background (raw data are indicated in appendix). 
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Figure 8 A:  Enzyme activity spot test on culture supernatant from PepG1 (mutated and non-
mutated) in B. subtilis strain A. The supernatant was spotted on casien at pH 6, after three days 
of fermentation in PS-1 at 37°C,. Spot plates were incubated at 50°C. The the intensity of blue 
halo around the spots represent an estimate of the protease activity. 1: non-mutated PepG1 2: 
PepG1 mutated in Q117 3: PepG1 mutated in Q117 + E199 4: the empty strain A host. B: 
Protease assay on culture supernatant after four days of fermentation in PS-1 at 37°C. Collagen 
was used as substrate at pH 2, incubated at 60°C for 45 min 1: non-mutated PepG1 2: PepG1 
mutated in Q117 3: PepG1 mutated in Q117 + E199.  4: background activity from empty strain A 
host. Represents the mean value of relative actvity in OD590 (n=3). All values was corrected with 
the mean value of the blinds (n=3). The error bars shown are +/- the standard deviation (n=3).  
* Represents statistically significant differences from the background activity (4). Raw data are 
indicated in appendix. 
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The heat and acid treated supernatants were analyzed by SDS-page (described in 7.14). Bands 
corresponding to PepG1 in size (25.12 kDa after cleavage of the signal peptide) were 
identified around 25 kDa (Figure 9) 
 
 
 
 
 
 
 
 
 
 
 
8.2.5 N-terminal sequencing of mutated and non-mutated PepG1  
N-terminal sequencing was carried out on the proteins corresponding to PepG1 (according to 
7.19). The sequencing confirmed expected the sequences. 50% of the sequencing showed: 
AQNFGWS  (corresponding to residues 57-63, of PepG1 with signal peptide) as the starting 
sequence, 50% showed: NFGWSAS (corresponding to residues 59-63, of PepG1 with signal 
peptide) as the starting sequence. In addition, it was confirmed that the E199 mutation was 
introduced to the double mutated protein. Unfortunately, there was no mass spectroscopy 
coverage of Q117. 
 
8.3 Expression of AsaG1 and CmaG1 in B. subtilis strain B   
Expression of the putative archaeal G1 proteases, AsaG1 and CmaG1, were attempted in B. 
subtilis. This was done by generation of an integration cassette including the gene of interest 
flanked by two regions for homologous recombination (7.6). To ease purification, a C-
terminal 6xhis-tag was added to the genes. Expression was attempted in B. subtilis, strain A 
(described in 7.7). The integration cassette was transformed into B. subtilis and incorporated 
on the genome by homologous recombination (described in 7.7). PCR on colonies was used 
for verifying integration of the cassette, the genes of interest were amplified, and correct 
sequences of the inserts were verified by DNA sequencing of the entire PCR products (7.4 
and 7.7). 
Figure 9: SDS gel of PepG1 culture supernatants 
(mutated and non-mutated), which were fermented 
in PS-1 at 30°C for four days. The supernatants 
were heat treated at 70°C and treated with 
hydrochloric acid, followed by centrifugation. 1: 
Non-mutated PepG1 2: PepG1 mutated in Q117 3: 
PepG1 mutated in Q117 and E199 4:  the empty 
host of strain. The theoretical mass of PepG1 is 
25.12 kDa (after cleavage of the signal peptide) M: 
Page ruler™ (thermo scientific).  
 
   kDa M 1 2 3 4
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8.3.1 Creation of Fragment 2 of AsaG1 and CmaG1 
The AsaG1 and CmaG1 genes were PCR amplified creating fragment 2. Fragment 1 and 3 
were PCR amplified from B. subtilis iMB1361 genome DNA (descirbed in 7.6). The 
following fragments were amplified: 
 
Fragment 1:   5184 bp 
Fragment 2 CmaG1: 866 bp 
Fragment 2 AsaG1:  740 bp 
Fragment 3:    2904 bp  
After amplification of fragment 1,2 and 3 the fragments were assembled by SOE-PCR, 
creating the integration cassette (Described in 7.6, Figure 10)
 
 
 
 
 
 
 
 
 
8.3.2 Transformation of integration cassettes of AsaG1 and CmaG1 into B. subtilis Strain A 
The integration casettes were cloned into expression strain A as described in 7.7. Eight of 
each clones were picked, the inserts were amplified by colony PCR and loaded on an agarose 
gel. The inserts (of the correct size) of seven of the clones were observed on the agarose gel. 
Three of each observed insert were purified and the entire genes of interest were DNA 
sequenced from both strands, which confirm one of the integration sequences (described in 
7.4 and 7.7).  
8.3.3 Activity spot tests of AsaG1 and CmaG1 B. subtilis strain A clones.  
The verified clones were fermented in PS-1 at 30°C as described 7.8. After four and five days 
of fermentation, the culture supernatants of the AsaG1 and CmaG1 B. subtilis clones were 
spotted on AZCL collagen (pH 4, 6 and 8) and casein (pH 6) (described in 7.14). The empty 
strain A was spotted as a background activity control. The plates were incubated at 37°C or 
Figure 10: Agarose gel illustraing the 
SOE-PCR products of AsaG1 and 
CmaG1 from agarose gel. Fragment 1, 2, 
and 3 were assembled to create the SOE-
PCR product (integration cassette). The 
expected sizes of the products were: 
AsaG1: 8088 bp, CmaG1: 8954 bp. The 
topmost bands corresponded to the size 
of the theoretic SOE-PCR products 
(other bands might be unassembled 
fragments). M: Hyperladder™ I marker 
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50°C. Activity was only observed on collagen pH 6, but at the same intensity as the 
background control. Therefore the results are not shown. Additionally, the culture 
supernatants were spotted on skim milk plates as illustrated in Table 11 (described in 7.14). 
Since AsaG1 and CmaG1 were presumed to be heat stable, the culture supernatant was heat 
treated at 80°C before skim milk spot test, as described in 7.14.   
Haet treated 80°C
Incubation temperature 37°C 50°C 37°C 50°C
PH : 5 6 8 5 6 8 6 6
AsaG1-Strain A 10 mm 16 mm 16 mm 0 17 mm 15 mm 0 0
CmaG1-Strain A 10 mm 16 mm 16 mm 0 17 mm 15 mm 0 0
Strain A 7 mm 12 mm 13 mm 0 14 mm 8 mm 0 0
 
Table 11: Enzyme activity from skim milk spot tests. The culture supernatant of B. subtilis strain A clones and 
the empty host (strain A) was spotted, after four days of fermentation in PS-1 at 37°C. pH of the substrate and 
the incubation temperature of the plates are indicated. The radius (in mm) of the clearing zone around the spots 
provides an estimate of the protease activity.  
 
The culture supernatants were also spotted on skim milk at pH 7,9, and 10 and incubated at 
37°C, 50°C and 70°C, but the results in Table 11 were the most substantial, since all other 
tests showed lower differences (if any) in the activity between samples and controls.    
8.3.4 SDS-page and his-tag purification of AsaG1and CmaG1 from B. subtilis strain A 
clones 
A SDS-page was performed on culture supernatant of the clones and the empty A strain, 
fermented in PS-1 in at 30°C at four days (described in 7.14). The gel included a lot of 
background proteins. No bands corresponding to AsaG1 or CmaG1 (different from bands in 
the empty strain A) were observed. The gel is therefore not shown. The same culture 
supernatants were purified by his-tag column as described in 7.15. The SDS-page of the 
purified supernatants is shown in Figure 12. 
 
 
 
 
 
 
 
 
 
kDa M Strain A AsaG1 CmaG1 Figure 12: SDS gel of his-tag purified 
culture supernatants from AsaG1 and 
CmaG1 clones in Strain A. The clones 
were fermented in PS-1 at 30°C for four 
days. Strain A represent the culture 
supernatant of the empty host, purified 
by his-tag column. AsaG1 and CmaG1 
have a theoretical masses of  26.92 and 
24.93 kDa respectively, (after cleavage 
of the signal peptides). M: Page ruler™ 
(Thermo scientific) 
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Since a low concentration of imidazole was used in the binding buffer used for the washing 
step (His SpinTrap kit (GE Healthcare)), several background proteins were present. A band 
was showed around 35 kDa in AsaG1 and CmaG1, which was not visible in the control.  
The his-tag purified supernatants were spotted on skim milk plates at pH 5 and 8 (the samples 
with most activity compared to control in Table 11) as described in 7.14. These were 
incubated at 37°C and 50°C. None of the tests showed any activity.  
8.3.5 Expression of AsaG1 and CmaG1 in B. subtilis strain B  
Because expression could not be confirmed in strain A AsaG1 and CmaG1 were also 
expressed in the protease deficient B. subtilis strain B by the same procedure as strain A 
(described in 7.10). The integration cassettes showed in Figure 10 were transformed into 
strain B as described in 7.7.  Eight clones were picked; the inserts were amplified by colony 
PCR and loaded on an agarose gel (described in 7.7). The insert of seven clones of CmaG1 
and three clones of AsaG1 (of the correct size) were observed on the agarose gel. The entire 
sequences oftwoof each genes of interest were DNA sequenced from both strands, (according 
to 7.4). This confirmed one of the sequences. The clones were fermented in CAL-18 at 37°C 
for four days as described in 7.8. The culture supernatant was assayed on casein plates at pH 6 
and skim milk pH 5 and 8 at 37°C and 50°C as described in 7.14. No activity was observed in 
either the control or the clones. Additionally no bands corresponding to AsaG1 and CmaG1 
were observed on the SDS-page performed on the supernatant as described in 7.14. The Data 
are not shown.    
Because expression in B. subtilis strain A or B could not be confirmed, no further experiments 
were performed in the host. Therefore, the mutated genes of AsaG1 and CmaG1 (prepared as 
described in 7.5) were never cloned into B. subtilis.  
 
8.4 A. oryzae expression of AsaG1 and CmaG1   
Expression of AsaG1 and CmaG1 were attempted in A. oryzae. This was done by cloning the 
gene of interest into expression vector pDau109 as described in 7.9. To ease purification, a C-
terminal 6xhis-tag was added to the two genes. The recombinant pDau109 was transformed 
into E. coli as described in 7.9. Eight of each clone were picked, amplified from colonies by 
PCR, and loaded on agarose gel to verify integration of the gene of interest in the vector as 
described in 7.9. The inserts (of the correct sizes) of all clones were observed on the agarose 
gel. One of each construct was isolated from the gel and the correct sequences of the inserts 
were verified by DNA sequencing of the PCR products (described in 7.4). The verified 
recombinant pDau109 was plasmid purified (described in 7.9) followed by transformation 
into A. oryzae MT3568 (described in 7.10).   
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   kDa M AsaG1 CmaG1 MT3568
 
8.4.1 SDS-page and N-terminal sequencing of AsaG1 and CmaG1 MT3568 clones  
The clones were fermented in shaking flasks with YP 2% glucose, DAP-4C-1 and FG-4 at 
30°C and 37°C as described in 7.11. SDS-pages was performed on the culture supernatants. 
The SDS-page of the clones grown in DAP-4C-1 and FG-4 (described in 7.14) showed no 
bands corresponding to AsaG1 or CmaG1 (that was not observed empty strain MT3568). This 
was also the case for clones grown in 2% glucose at 37°C. The gels are therefore not shown. 
A band around 25 kDa was observed in the SDS-Page performed on supernatant of the 
CmaG1 clone grown in YP 2% glucose at 30°C (Figure 13). A similar, but weaker band was 
observed for AsaG1. It was not possible to see this band for the empty MT3568 host (Figure 
13). The bands were corresponding to AsaG1 and CmaG1 with theoretical masses of 26.92 
and 24.93 kDa respectively (after cleavage of the signal peptide). N-terminal sequencing was 
carried out on the proteins corresponding to these bands (according to 7.19). The proteins 
were non-characterized secreted proteins native to A. oryzae. 
 
    
 
 
 
 
 
 
 
 
 
 
 
8.4.2 Enzyme activity spot and protease assay of AsaG1 and CmaG1 MT3568 clones 
Enzyme activity spot tests were carried out on the culture supernatant after four and five days 
of fermentation of the MT3568 clones as described in 7.14. Casein and collagen, at pH 6 and 
skim milk at pH 5 were used as substrates. The plates were incubated at 50°C. There was no 
activity on either collagen or skim milk plates after four days of fermentation. Furthermore no 
activity was observed for AsaG1 on casein. The activity of CmaG1 was slightly higher than 
the empty MT3568 host on casein after four days of fermentation. However, after five days of 
fermentation the activities were similar (Figure 14). In addition, the culture supernatant from 
Figure 13: SDS-page of culture 
supernatants of AsaG1 and CmaG1 A. 
oryzae clones. The clones were 
fermented in YP 2% glucose at 30°C for 
four days. AsaG1 and CmaG1 represent 
the culture supernatant of the MT3568 
clones. MT3568 represent the culture 
supernatant of the empty host. AsaG1 
and CmaG1 have a theoretical mass of 
26.92 and 24.93 kDa respectively, after 
cleavage of the signal peptides .M: Page 
ruler™ (thermo scientific)   
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CmaG1 clones was heat treated at 70°C as described in 7.14. After the treatment no activity 
was observed (Figure 14) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Protease activity assays (described in 7.16) were carried out on the culture supernatant of the 
MT3568 clones after five days of fermentation in YP 2% glucose at 30°C (described in 7.11). 
Collagen and casein were used at substrates at pH 2 and 3 (described in 7.14). No activity was 
observed in either of the samples or the empty MT3568 host. The results are therefore not 
shown (data not shown in appendix).  
Since activity could not be confirmed in the A. oryzae clones, His-tag purification was not 
performed.
 
8.5 E. Coli expression of AsaG1 and CmaG1   
Since expression could not be confirmed in A. oryzae and B. subtilis, intracellular expression 
of AsaG1 and CmaG1 was attempted in E. coli. This was done by cloning of the B. subtilis 
codon optimized AsaG1 and CmaG1 genes into expression vector pET-32a(+) which was 
transformed into E. coli (stellar®), as described in  7.12 and 7.13. Eight clones were picked 
and inserts were amplified by PCR on colonies. The inserts were loaded on an agarose gel 
(described in 7.9). The inserts (of the correct size) was observed in 7 of the clones on the 
agarose gel. DNA sequencing (according to 7.4) oftwoof these verified the sequence of the 
one of the inserts, the entire gene of interest was sequences. The recombinant pET-32a(+) was 
plasmid purified and transformed into E. coli expression strain XJb Autolysis™ to obtain 
intracellular expression (described in 7.13). The clones were fermented as described in and 
lysed by a freeze-thaw cycle is described in 7.13. 
SDS-page (described in 7.14) was carried out on the lysis supernatant, prepared as described 
in 7.13. The gel showed no bands corresponding to AsaG1 or CmaG1 that differed from the 
Figure 14: Enzyme activity spot  test on 
fermentaion extract from MT3568 
CmaG1 clone and the empty MT3568 
strain. Were fermented in YP 2% glucose 
at 30°C. Was spotted on casien plates at 
pH 6 and incubated at 50°C for 12 hours. 
The the intensity of blue halo around the 
spots represent an estimate of the 
protease activity. A: test after four days 
of fermentation. B: test after 5 days of 
fermentation. 7: MT3568 CmaG1 clone, 
7W: 7 that was heat treated at 70°C, 9: 
empty MT3568 host  
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empty XJb Autolysis™ host, either for clones fermented at 30°C or 37°C. Therefore the gel 
are not shown.  
The culture supernatants were spotted on AZCL casein pH 5 and 6, AZCL collagen pH 6 and 
skim milk pH 6 as described in 7.14. These were incubated at 50°C. No activity was observed 
on any of the plates, of either the clones or the empty XJb Autolysis™ host. Therefore no 
further experiments were done, and the culture supernatant was not purified by his-tag 
column.   
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9.  Discussion 
 
A multiple sequence amino acid alignment of the characterized proteases and archaeal 
putative proteases was performed (Figure 6). Even though the overall identity between the 
archaeal putative G1 proteases and the characterized G1 protease is low (between 19% and 
28%), the alignment indicates several residues that are conserved in the aligned proteins. 
Furthermore, the conserved motifs, identified by Fujinaga et al. [20], are present in the 
archaeal proteins. The catalytic dyad, consisting of Q and E, is conserved in all the aligned 
proteins. These findings indicate that there might be structural similarities between AsaG1 
and CmaG1, and the G1 proteases. It is therefore evident to believe that the archaeal proteins 
might share characteristics with the G1 familie.   
One focus of this study was to express the archaeal genes AsaG1 and CmaG1, to get enzyme 
concentrations high enough to perform characterization of the enzymes. The host organism 
used for expression must not only be able to secrete high levels of enzymes, but also be able 
to express archaeal genes. Archaeal genetics share traits with both bacterial and eukaryotic 
genetics, and have their own specificities [6, 11]. Therefore it is difficult to predict which 
non-archaeal model organisms are capable of heterologous expression of specific archaeal 
genes. Consequently both the eukaryote A. oryzae and the bacteria B. subtilis were chosen for 
the expression of AsaG1 and CmaG1. Furthermore, the genes were codon optimized for the 
host organism to obtain as high expression as possible [34, 35].  
 
Since the bacterial G1 Protease PepG1 has earlier been expressed in B. subtilis [9], this 
organism might be a good choice of expression host of the archaeal putative G1 proteases. 
Expression of AsaG1 and CmaG1 were attempted in B. subtilis. Clones were grown in 
different growth media at different temperatures (indicated in 8.3.3). Expression of AsaG1 
and CmaG1 could not be confirmed in B. subtilis strain A by SDS-Page analysis or AZCL 
spot tests (8.3.3, 8.3.4). The activity was slightly higher of CmaG1 and AsaG1 compared to 
the empty strain A host on skim milk plates (Table 11). Yet, the difference was not evident 
enough to conclude that AsaG1 and CmaG1 were active, since the activity might be caused by 
host background activity. Furthermore, all activity was lost when the supernatant was heat 
treated before the spot test (Table 11). It is assumed that the archaeal putative G1 proteases 
are thermostable, since they originate from thermophilic organisms [12, 14] and are believed 
to have stability similar to the G1 proteases. Therefore, the loss of activity after heat treatment 
indicates that the activity observed on skim milk was background activity (Table 11). The 
SDS-gels from the culture supernatant of the AsaG1 and CmaG1 B. subtilis included a lot of 
background proteins. Even though no bands corresponding to the archaeal proteins were 
observed, these could possibly be covered by background proteins. Therefore, the culture 
supernatant was purified by his-tag column (described in 7.15 and 8.3.4). After his-tag 
purification, bands were observed at around 35 kDa on SDS-page, which was not observed in 
the empty host (Figure 12). Even though, this was more than the theoretical size of AsaG1 
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and CmaG1 (26.92 and 24.93 kDa respectively, after cleavage of the signal peptide), these 
could possibly be the archaeal proteases, since the proteins can be post transcriptional 
modulated and for example undergo glycosylation. Though, all protease activity was lost after 
the his-tag purification (8.3.4). Therefore it was assumed that the observed bands (Figure 12) 
were not AsaG1 and CmaG1. This could indicate that the proteases were not expressed in 
strain A, or that it was not possible to his-tag purify the proteins, which can be caused by post 
translational cleavage of the his-tag. Another explanation might be a lacking activity of 
expressed enzymes. Since inactive enzymes cannot be characterized, this was however 
irrelevant.  
Expression was attempted in protease deficient strain B since expression of AsaG1 and 
CmaG1 could not be confirmed in strain A. The theory was that some of the cellular 
proteases, present I strain A, were involved in cleavage of the recombinant enzymes, which 
might lead to degradation or deactivation of the enzymes. This could possibly be prevented by 
expression in the protease deficient strain B. Furthermore, less background protease activity 
was present in the strain B, which makes it easier to distinguish between recombinant enzyme 
activity and background activity. The SDS-page and activity spot tests showed no sign of 
expression in the strain B (8.3.5). It was therefore assumed that the archaeal putative G1 
proteases could not be expressed in B. subtilis strain A or B under the applied conditions, or 
were expressed in concentrations, too low to observe. 
 
Expression of AsaG1 and CmaG1 was attempted in A. oryzae. Clones were grown in different 
growth media at different temperatures (indicated in 8.4.2). When grown in YP + 2% at 30°C, 
bands corresponding in size to AsaG1 and CmaG1 were visible, but were not visible in the 
control (Figure 13). The N-terminal sequencing showed that these enzymes were native A. 
oryzae proteins (8.4.1). Expression could not be confirmed in other SDS-page’s (8.4.1). No 
activity was present, besides CmaG1 when spotted at 50°C with casein as substrate at pH 6. 
After four days of fermentation, the activity was higher than the control, but after five days 
the activity was similar (Figure 14). In addition this was the only substrate and pH that gave 
rise to background activity (8.4.2). Therefore, it was believed that the observed activity was 
caused by background host enzymes. Since AsaG1 and CmaG1 originate from acidophilic 
organism, it was supposed that the enzymes might only be active at low pH (around pH 2-3). 
In addition, the characterized G1 proteases are active in this range [10]. Therefore a protease 
assay was carried out at pH 2 and 3 with collagen and casein as substrates (described in 7.16 
and 8.4.2). No activity was observed in the assays. These observations led to the assumption 
that the archaeal enzymes were not expressed in A. oryzae, or were expressed in to low 
concentrations to indentify activity. 
 
As expression could not be obtained in either A. oryzae or B. subtilis, AsaG1 and CmaG1 
were cloned into E. coli in the expression vector pET-32a(+) and expressed in the E. coli 
expression strain XJb Autolysis™. AsaG1 and CmaG1 might be expressed in A. oryzae or B. 
subtilis, but not secreted from the cells. This would explain the lack of both activity and 
proteins in SDS-page’s, since the supernatant of the culture was used. Furthermore, the 
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enzymes might be cleaved after translation or secretion, which might lead to loss of catalytic 
activity or complete degradation. This could possibly be prevented by intracellular expression 
in E. coli followed by lysis of the cell, and thereby release of the unprocessed enzymes. 
AsaG1 and CmaG1 was cloned into pET-32a(+) and transformed into E. coli expression strain 
XJb Autolysis™ (described in 7.12, 7.13 and 8.5). The cells fermented in LB for 12 hours and 
lysed to release the recombinant enzymes (described in 7.13). Expression could not be 
confirmed in E. coli. either by SDS-page or activity spot tests (8.5). This can probably be 
explained by the use of B. subtilis optimized genes in E. coli. On the other hand, codon 
optimization is not necessarily needed for heterologous expression of bacillus genes in E. coli. 
The lack of expression might be caused by lack of particular post translational events.    
Three different organisms were used as host organisms in attempts of heterologous expression 
of AsaG1 and CmaG1. These were grown in different media at different temperatures. Genes 
were codon optimized for the organism in which they were expressed in. since archaeal 
genetics are unique, codon optimization might be essential to perform heterologous 
expression of their genes [6, 8]. Finally, some signal peptides of archaea are unique, and 
specified for archaeal excretion [47]. Therefore, the native signal peptides of AsaG1 and 
CmaG1 were replaced with signal peptides used by the expression hosts (Servinase for B. 
subtilis and a signal peptide from Candida Antarctica for A. oryzae). Still, it was not possible 
to confirm expression of the archaeal putative G1 proteases. This disproves the hypothesis 
that that codon optimized AsaG1 and CmaG1 genes can be expressed in A. oryzae and B. 
subtilis. However there was still the possibility that AsaG1 or CmaG1 were expressed in very 
low concentrations, and the proteins might be covered by background proteins on SDS-
page’s.  If a low concentration is expressed, it can be showed by a western blot, with use of 
anti-his antibodies the binds the 6Xhis-tag added to both AsaG1 and CmaG1. Still the focus of 
this study was to characterize the archaeal enzymes, which is not possible when activity could 
not be proven. Therefore a western blot was not considered relevant.  
There could be several explanations for the lack of expression of the archaeal enzymes; 
growth in acidic medium or high fermentation temperature might be necessary to express the 
enzymes, since the enzymes originate from acidothermophilic organisms. It has earlier been 
shown that increased fermentation temperatures increase the activity of heterologously 
expressed thermostable proteins [48], which might also be the case for AsaG1 and CmaG1. 
Therefore, it could be interesting, to express AsaG1 and CmaG1 in organisms, that was able 
to grow at higher temperatures and/or lower pH. Another explanation on the lack of 
expression could be that thermostable archaea enzymes need specific post-translational events 
to be activated, including protein processing or folding for example by unique archaea 
chaperons [49, 50]. The lack of the mechanisms in non-archaeal mesophilic expression hosts 
applied in this study, might lead to loss of activity or lack of secretion of the enzymes. 
Therefore, it might be effective to express the enzymes in their original hosts or other archaeal 
host. The expression could be done in the archaea model organism Sulfolobus acidocaldarius, 
which have earlier been used for overexpression of recombinant proteins [51]. On the other 
hand expression in known expression systems is easy to work with and the hosts are able to 
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secrete large amounts of enzyme, which is considered an advantage compared to expression 
in for example archaea [5, 52].  
Since the attempts of expression of AsaG1 and CmaG1 showed no signs of activity, it was not 
possible to test the hypothesis that AsaG1 and CmaG1 have characteristics similar to those of 
the characterized G1 proteases. Though, a qualified guess would be that their characteristics 
are similar, based on the alignment analysis (Figure 6), which shows homology, in the 
conserved boxes between and presence of the catalytic Q and E residues in the archaeal 
sequences. Still, it is not evident to believe that there is any similarity in their enzymatic 
characteristics. In addition, it is possible that AsaG1 and CmaG1 is mutationally inactivated 
pseudogenes in their native archaeal organisms of A. saccharovorans and C. maquilingensis 
respectively [53]. Therefore it might not be possible to characterize the enzymes.   
The two highly conserved residues of Q117 and E199 of PepG1, was substituted with alanine 
residue by site-directed mutagenesis (7.5) to investigate the importance of these residues. It 
was confirmed that the mutation was introduced by DNA sequencing of the mutated genes 
(8.2). PepG1 has earlier been expressed in B. subtilis [9]. In this study, the mutated, the 
double-mutated and the non-mutated PepG1 were expressed in a different B. subtilis strain 
(strain A) (8.2.2). Expression of the non-mutated PepG1 and activity test of the culture 
supernatant on spot plates and protease assay showed an evident activity compared to the 
background host activity (Figure 8 A+B). PepG1, that was mutated in Q117 and in 
Q117+E199 showed no significant difference from the background activity, either on spot 
tests or in the protease assay (Figure 8 A and B). This indicates that mutation leads to loss of 
enzymatic activity of PepG1. To confirm this, expression had to be confirmed in all the 
clones, since the lack of activity might be caused by absence of the mutated enzymes in the 
culture supernatant. Expression was confirmed by heat- and acid-treatment followed by 
centrifugation (as described in 8.2.4), which denatured background enzymes and the 
thermoacidophilic enzymes was thereby isolated. These were analyzed by SDS-page, which 
showed bands corresponding to PepG1 in size in both the mutated, the double mutated and the 
non-mutated clones (Figure 9). It was proven by N-terminal sequencing that these bands were 
PepG1 (8.2.5). It was thereby confirmed that both: the non-mutated, the Q117 mutated and 
the Q117+E199 mutated enzymes were secreted, but that only the non-mutated had protease 
activity (Figure 2). This confirms the hypothesis, that mutation of the Q117 and E199 leads to 
loss of enzymatic activity of PepG1. Thereby it is suggested that these residues are involved 
in the proteolytic activity and that the activity relies on their existence. In fact, the enzyme 
activity was already lost after substitution of Q117, which indicates that both residues are 
independently essential. Therefore it is presumed, that Q117 and E199 constitutes a catalytic 
dyad.  
Even though the catalytic Q and E residues are conserved in all G1, and are assumed to be 
essential for catalytic activity of all members of the family, it has only been proven for the 
two founding enzymes of AGP and SGP by 3D structures and site-directed mutagenesis [20, 
22, 25–27]. Still four other enzymes, including PepG1, have been annotated to the family 
[10]. PepG1 is the only bacterial enzyme classified as G1 protease. It has been classified 
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primarily because: the amino acid sequence encompasses the conserved mortifs and the 
conserved catalytic Q and E residues, PepG1 has catalytic characteristics similar to the 
characterized G1 proteases and was not inhibited by pepstatin [9]. The catalytic dyad 
consisting of the Q and E residue gave the G1 family the name Eqolisins, and the two 
conserved residues is one of the most important characteristics of the G1 protease [10, 54]. 
The findings of this study show that these residues are essential of the activity of the bacterial 
G1 protease PepG1, which indicates that PepG1 have catalytic mechanisms similar to the 
founding G1 proteases AGP and SGP. Thereby there is strong evidence that PepG1 is 
correctly classified as G1 protease. 
10. Perspectives  
 
Even though PepG1 share several characteristics with the characterized fungal G1 proteases, 
crystallography of the PepG1 protein structure have never been performed. 3D structures are 
available of both AGP and SGP. The two structures are similar and confirm that the 
conserved dyad of Q and E is part of the catalytic site [20, 22]. It would therefore be 
interesting to determine the molecular 3D structure of PepG1, to confirm that the protein have 
a molecular structure similar to AGP and SGP, and prove that the essential Q and E residues 
are part of the catalytic site. 
 
G1 proteases are not yet applied in industrial processes. Still AGP has showed promising 
results in degradation of heat unstable proteins during production of wine, which is an 
important step of white winemaking to prevent appearance of haze in the bottled wine. AGP 
are active under the acidic wine pH, and at temperatures that leads to unfolding of the wine 
proteins, which makes them easy to degrade. APG showed a total wine protein reduction of 
≈90% when heated to 75°C for one min [55]. Therefore the G1 proteases seem to be 
potentially applied in this field, and it could be interesting to test other G1 proteases in a 
similar study.    
 
Until now the biological function of G1 proteases is unknown. Still some qualified 
suggestions has been made: it is assumed that Scytalidium lignicolum, which is a tree 
degrading fungus, uses the SGP for degradation of tree proteins [54]. 
In addition it has been suggested that the fungal species that are pathogenic to plants, might 
use G1 proteases for plant cell wall proteins degradation [9]. It could be interesting to 
investigate the in vivo function of the fungal and bacterial G1 proteases.  
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Appendix 
 
Primer sequences 
 
AsaG1-Q97fw:      5'-GGCTTTAATGATAGCACAGTTGAAGCTACAGGCATTCTGGTCCAATG-3'   
AsaG1-Q97rv:      5'-CATTGGACCAGAATGCCTGTAGCTTCAACTGTGCTATCATTAAAGCC-3'   
AsaG1-E183fw:     5'-AGCAGAATGGGTTGTTGCTAGACCGGCAGTTGGCG-3'   
AsaG1-E183rv:     5'-CGCCAACTGCCGGTCTAGCAACAACCCATTCTGCT-3'   
CmaG1-Q92fw:      5'-TATAATGATACAACAGTTGAAGCTGCAGGCATTGCAGTTGAATGCG-3'   
CmaG1-Q92rv:      5'-CGCATTCAACTGCAATGCCTGCAGCTTCAACTGTTGTATCATTATA-3'   
CmaG1-E175fw:     5'-CAGCAGAATGCATCCTGGCTAGACCGGTTGTTAATGGC-3'   
CmaG1-E175rv:     5'-GCCATTAACAACCGGTCTAGCCAGGATGCATTCTGCTG-3'   
PepG1-Q82 fw:     5'-CGGCTTTAACAACTCTGATTTAATCGCCACAGGTACGGAACAAGACTACG-3'   
PepG1-Q82 rv:     5'-CGTAGTCTTGTTCCGTACCTGTGGCGATTAAATCAGAGTTGTTAAAGCCG-3'   
PepG1-E164 fw:    5'-CGGAATGGATCCAGGCCGCACCTGAGATCGGC-3'  
PepG1-E164 rv:    5'-GCCGATCTCAGGTGCGGCCTGGATCCATTCCG-3'   
 
Mismatches are underlined  
 
Asa/CmaG1 Seq fw: 5'-CGACGTTGTAAAACGACGG-3'  
Asa/CmaG1 Seq rw: 5'-GCTATGACCATGTTAATGCA-3'  
PepG1-F2 fw:      5'-GTTCATCGATCGCATCGGCTAGCCCTGCTATTTTTCATGCGCC-3' 
PepG1-F2 rv:      5'-GCGTTTTTTTATTGATTAACGCGTTTAAGAAGCTGGAGGAGAAGGTTGGT-3' 
 
PepG1-F2 fw:      5'-GTTCATCGATCGCATCGGCTAGCCCTGCTATTTTTCATGCGCC-3'   
PepG1-F2 rv:      5'-GCGTTTTTTTATTGATTAACGCGTTTAAGAAGCTGGAGGAGAAGGTTGGT-3'   
AsaG1-F2 fw:      5'-GTTCATCGATCGCATCGGCTGCAAGAGCACAAGCAAAACTGTATCCG-3'   
AsaG1-F2 rv:      5'-GCGTTTAGTGGTGATGGTGATGATGTTTGCCATGATGTCCGCCTGAG-3'   
CmaG1-F2 fw:      5'-GTTCATCGATCGCATCGGCTATTCTGATTAGCCACCCGATGATTAAACAAG-3'   
CmaG1-F2rv:       5'-GCGTTTAGTGGTGATGGTGATGATGGCCATATGTGACTGTAAATGATGAGCCA-
3'   
 
The overlaps are indicated in bold. The 6xhis-tags are underlined.  
 
F1 fw:          5'-GAGTATCGCCAGTAAGGGGCG-3' 
F1 rv:         5'-AGCCGATGCGATCGATGAACTA-3' 
F3 fw:         5'-CATCATCACCATCACCACTAAACGCGTTAATCAATAAAAAAAC-3' 
F3 rw:             5'-GCAGCCCTAAAATCGCATAAAGC-3' 
 
The his-tag is underlined. 
Bac-colony fw:     5'-CATATATTTGCACCGTCTAATG-3' 
Bac-colony rv      5'-TTAAAGGATTTGAGCGTAGC-3' 
 
AsaG1 oryzae fw:   5'-GGTGAAGCGTACGCGTGCCAGGGCCCAGGCCAAGCT-3' 
AsaG1 oryzae rv:   5'-ATGGTGATGCGCACGCGTCTTGCCGTGGTGCCCTCCGC-3' 
CmaG1 oryzae fw:   5'-GGTGAAGCGTACGCGTATCCTCATCTCCCATCCTATGATCAAGC-3' 
CmaG1 oryzae rv:   5'-ATGGTGATGCGCACGCGTGCCGTAGGTGACGGTGAAGGA-3' 
 
The overlaps are indicated in bold. His-tags are underlined 
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Pna-fw:          5'-CCCTTGTCGATGCGATGTATC-3' 
Tamg-rv:           5'-ATCCTCAATTCCGTCGGTCGA-3' 
Asa-coli fw:       5´-GGAGATATACATATGGCAAGAGCACAAGCAAAACT-3’ 
Asa-coli Rv:       5´-GTGGTGGTGCTCGAGTTTGCCATGATGTCCGCCTG-3’ 
Cma-coli Fw:       5´-GGAGATATACATATGATTCTGATTAGCCACCCGAT-3’ 
CmaG1-coli rv:     5´-GTGGTGGTGCTCGAGGCCATATGTGACTGTAAATGATGAG -3’ 
The 15 bp overlaps are indicated in bold. The restriction sites are underlined (NdeI: CATATG, XhoI: 
CTCGAG). 
 
 DNA sequence of AsaG1, codon optimized for B. subtilis: 
GCAAGAGCACAAGCAAAACTGTATCCGAGACTGCCGCTGAGAGGCTCAACATCAGAATCA 
CTGAATTGGGCAGGCTATGCAGATGTTCTGGCACCGCATTCATTTATTTCAGTTAATGCA 
TCATGGTATGTCCCGGATGTTCAATGCTCACCGAGATCATCAGATGTTGCAGTTTGGGTT 
GGCATTGATGGCTTTAATGATAGCACAGTTGAACAGACAGGCATTCTGGTCCAATGCCAA 
GGCGGACGCGCATATTATTCAGCATGGTATGAATTTTATCCGGCATCACCGGTTTATGCA 
CCGTCATCATATGTCGTTAGACCTGGCGATAAAGTTGTTGGCTGGGTTATCTATAATACA 
AGCACAGGCGAATATCGCACAGTTCTGGTTGATGTTACACAAGGCTGGAATTTTACATCA 
CCGTGGACAGCAGTTTCAGGCGCTGAAGATTCATCAGCAGAATGGGTTGTTGAAAGACCG 
GCAGTTGGCGGATCACTGACAACACTGGCAGATTTTGGCACAGCGTATTTTAACGTCAAA 
TATACAGGCGTTCTTCCGCCTGGCGGAGTTTATGTTAGACTGGCAAATGGCTCAGCAGGC 
AATATTTCAAGCTTTAACTACTATGAAATGATCATGGTCAACGACCAAGGCAAAGTTCTT 
GCACAACCGTCAGGCCTGTATGCATATGGCTCATCATTTTATGTTTGCTATGGACCGTGC 
GGCTCATCAGGCTCAGGCGGACATCATGGCAAA 
 
DNA sequence of AsaG1, codon optimized for A. oryzae: 
 
GCCAGGGCCCAGGCCAAGCTCTACCCGAGGCTCCCGCTCAGGGGCTCGACGAGCGAGAGC 
CTCAACTGGGCCGGCTACGCAGACGTACTTGCACCTCACTCGTTCATATCTGTAAACGCC 
AGCTGGTACGTGCCCGACGTGCAGTGCAGCCCCAGGAGCAGCGACGTGGCAGTATGGGTT 
GGCATAGACGGCTTCAACGACAGCACGGTGGAGCAGACCGGCATACTTGTGCAGTGCCAG 
GGCGGCAGGGCATACTACAGCGCGTGGTACGAGTTCTACCCTGCGTCCCCGGTTTACGCG 
CCCTCAAGCTATGTTGTGAGGCCAGGCGACAAGGTCGTCGGCTGGGTCATCTACAACACC 
TCCACCGGCGAGTACAGGACGGTGCTAGTTGACGTCACCCAGGGCTGGAACTTCACCTCC 
CCGTGGACGGCCGTGAGCGGGGCGGAGGACAGCAGCGCTGAGTGGGTCGTCGAGCGGCCA 
GCTGTGGGAGGGAGCCTGACGACGCTCGCAGACTTCGGCACGGCCTACTTCAACGTCAAG 
TACACCGGTGTGCTGCCGCCCGGGGGAGTCTATGTGAGGCTGGCCAACGGCTCGGCAGGC 
AACATATCGAGCTTCAACTACTACGAAATGATTATGGTGAACGACCAGGGCAAGGTGCTG 
GCTCAGCCGTCGGGGCTCTACGCCTACGGCTCGAGCTTCTACGTCTGCTACGGCCCCTGC 
GGCTCGTCTGGCAGCGGAGGGCACCACGGCAAG 
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DNA sequence of CmaG1, codon optimized for B. subtilis: 
 
ATTCTGATTAGCCACCCGATGATTAAACAAGGCCTGACATCACTGTCATCATCAGTTTCA 
TCACTGAATTGGGCAGGCTATGCAGTTCCGGCAGAAAAAGGCACAGTTACATCAGTTGCA 
GGCTCATTTATTGTTCCGTCAGTTACATGCACAACAGGCCAAACAACATATGTCGCACTG 
TGGACAGGCCTGGATGGCTATAATGATACAACAGTTGAACAAGCAGGCATTGCAGTTGAA 
TGCGAAAATGGCAAACCGATTTATTGGGCGTGGTATGAATTTTATCCGTCACCGAGCGTT 
ACAATCAAAGGCTTTACAGTTAATCCGGGTGATGACATTTATGTCAACGTCACATATCTG 
GGCCATGGCAAATTTCAGGTCACAATTAAAGATGTCACAAAAAGCGAAGCGTATTCAACA 
ACAGGCAGAGTTTCAAAAGCAGAACTTTCATCAGCAGAATGCATCCTGGAAAGACCGGTT 
GTTAATGGCCAACTGTCATCTCTTGCAAATTTTGGCACAGCATATTATGGCCAGGATTAT 
ACATCAATCCTGGATACATGCTATGCAACAGTTTCAGGCGTTACAGGACCGTTTGGCCTT 
TTTCCGAGCGTTGTTAGCATTATTATGGTCAATAATTCAGGCGAAACACTGGCATATCCG 
TCATCACTTACATCAGATGGCTCATCATTTACAGTCACATATGGC 
 
DNA sequence of CmaG1, codon optimized for A. oryzae: 
 
ATCCTCATCTCCCATCCTATGATCAAGCAGGGCCTCACCTCCCTCAGCTCCTCCGTCAGC 
TCCCTCAACTGGGCCGGCTACGCCGTCCCTGCCGAGAAGGGCACCGTGACCTCCGTCGCC 
GGCTCCTTCATCGTCCCTTCCGTCACCTGTACCACCGGCCAGACCACCTACGTCGCCCTC 
TGGACCGGCCTCGATGGCTACAACGATACCACCGTCGAGCAGGCCGGTATCGCCGTCGAG 
TGCGAGAACGGCAAGCCTATCTACTGGGCCTGGTACGAGTTCTACCCTTCCCCATCCGTC 
ACCATCAAGGGCTTCACCGTCAACCCTGGTGATGATATCTACGTCAACGTCACCTACCTC 
GGCCATGGCAAGTTCCAGGTGACCATCAAGGATGTCACCAAGTCCGAGGCCTACTCCACC 
ACCGGTCGCGTCAGCAAGGCCGAGCTGTCCTCCGCCGAGTGCATCCTCGAGCGCCCTGTC 
GTCAACGGCCAGCTCTCCTCCCTCGCCAACTTCGGCACCGCCTACTACGGCCAGGATTAC 
ACCTCCATCCTCGATACCTGCTACGCCACCGTCAGCGGCGTCACCGGCCCTTTCGGCCTG 
TTCCCATCCGTCGTCAGCATCATCATGGTCAACAACTCCGGCGAAACCCTCGCCTACCCA 
TCCTCCCTGACCTCCGATGGCTCCTCCTTCACCGTCACCTACGGC 
 
DNA sequence of PepG1, codon optimized for B. subtilis: 
 
AGCCCTGCTATTTTTCATGCGCCACGTCATGCACTTTCTCCAAACACATCTCCAAAGCCA 
AACTCAGTGCAGGCTCAGAACTTCGGCTGGTCTGCAAGCAATTGGTCAGGTTATGCAGTT 
ACTGGCAGCACATACAACGATATTACGGGTTCTTGGATCGTTCCAGCAGTCTCACCTTCT 
AAACGTAGCACATATTCTTCATCTTGGATTGGTATTGACGGCTTTAACAACTCTGATTTA 
ATCCAAACAGGTACGGAACAAGACTACGTAAACGGACATGCTCAATACGATGCATGGTGG 
GAAATCCTTCCAGCTCCTGAAACTGTTATCTCTAATATGACAATCGCGCCTGGAGACCGT 
ATGTCAGCTCACATCCACAACAATGGTAACGGAACTTGGACAATCACTCTTACTGATGTG 
ACACGTAACGAAACTTTCAGCACAACACAATCATACAGCGGTCCTGGAAGCTCTGCGGAA 
TGGATCCAGGAAGCACCTGAGATCGGCGGCCGCATCGCGACTCTTGCAAACTATGGCGAA 
ACAACTTTCGATCCAGGTACAGTTAACGGTGGTAACCCTGGTTTCACTTTATCTGATGCA 
GGATACATGGTGCAAAACAATGCTGTGGTTTCAGTACCATCTGCACCAGACTCTGACACT 
GACGGATTCAACGTTGCTTATGGTTCAAACCAACCTTCTCCTCCAGCTTCTTAA 
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Amino acid sequence of AsaG1: 
 
MNPRYLALAALVILLAAAAPHGGGAARAQAKLYPRLPLRGSTSESLNWAGYADVLAPHSF 
ISVNASWYVPDVQCSPRSSDVAVWVGIDGFNDSTVEQTGILVQCQGGRAYYSAWYEFYPA 
SPVYAPSSYVVRPGDKVVGWVIYNTSTGEYRTVLVDVTQGWNFTSPWTAVSGAEDSSAEW 
VVERPAVGGSLTTLADFGTAYFNVKYTGVLPPGGVYVRLANGSAGNISSFNYYEMIMVND 
QGKVLAQPSGLYAYGSSFYVCYGPCGSSGSGGHHG 
 
The native signal peptide is underlined.  
 
Amino acid sequence of CmaG1: 
 
MLILTLIALAFAPLAVKPILISHPMIKQGLTSLSSSVSSLNWAGYAVPAEKGTVTSVAGS 
FIVPSVTCTTGQTTYVALWTGLDGYNDTTVEQAGIAVECENGKPIYWAWYEFYPSPSVTI 
KGFTVNPGDDIYVNVTYLGHGKFQVTIKDVTKSEAYSTTGRVSKAELSSAECILERPVVN 
GQLSSLANFGTAYYGQDYTSILDTCYATVSGVTGPFGLFPSVVSIIMVNNSGETLAYPSS 
LTSDGSSFTVTYG 
   
The native signal peptide is underlined.  
 
Amino acid sequence of PepG1: 
 
MNGTSVWKASGIAAASCLTAAALLAWPHATSTLDASPAIFHAPRHALSPNTSPKPNSVQA 
QNFGWSASNWSGYAVTGSTYNDITGSWIVPAVSPSKRSTYSSSWIGIDGFNNSDLIQTGT 
EQDYVNGHAQYDAWWEILPAPETVISNMTIAPGDRMSAHIHNNGNGTWTITLTDVTRNET 
FSTTQSYSGPGSSAEWIQEAPEIGGRIATLANYGETTFDPGTVNGGNPGFTLSDAGYMVQ 
NNAVVSVPSAPDSDTDGFNVAYGSNQPSPPAS 
 
The native signal peptide is underlined.  
 
Data from protease assay of PepG1   
 
Sample number PepG1 Q117 Q117+E199 Empty strian A Blind
1 0,3342 0,0729 0,091 0,0651 0,0959
2 0,3197 0,0712 0,0819 0,0792 0,0646
3 0,2697 0,1046 0,0703 0,08 0,0531  
OD590 is showed 
 
Data mini from protease assay of PepG1   
 PepG1 Q117 Q117+Q199 Empty strain A Blind
OD590 0,2021 0,0711 0,0665 0,0649 0,0562
